Titan records Rs 671 crore Damas put-option gain in September

Titan Company Limited recognised a Rs 671 crore gain in the quarter ended 30 September 2026 after remeasuring the liability linked to Damas LLC’s minority shareholders’ put option. The gain was recorded in consolidated profit and loss as a fair-value change of put-option liability over non-controlling interest, rather than as revenue from operations.

What created Titan’s Rs 671 crore gain?

Titan’s Rs 671 crore gain resulted from a decrease in the non-controlling interest, or NCI, put-option liability during the quarter ended 30 September 2026. Titan holds a call option to acquire the remaining 33% interest in Damas, while the minority shareholders hold a corresponding put option exercisable on 31 December 2029.

The filing says Titan remeasured the NCI put-option liability during the September 2026 quarter, and the lower liability produced the Rs 671 crore gain. It was recognised in the consolidated statement of profit and loss under “Fair value change of put option liability over NCI.”

This mechanism links the gain to the valuation of Titan’s obligation associated with Damas’s remaining 33% minority interest. The filing does not identify the Rs 671 crore as jewellery revenue, cash received, or a Damas operating-profit figure, and it does not disclose the liability’s closing balance, valuation assumptions or a separate tax amount for the gain.

How did Titan acquire its Damas stake?

Titan acquired control of Damas by buying a 67% equity interest through Titan Holdings International FZCO and Signature Jewellery Holding Limited for Rs 1,190 crore during the year ended 31 March 2026. Titan Holdings International FZCO is described as a wholly owned subsidiary of Titan.

Damas LLC appears in Titan’s subsidiary list as consolidated from 1 February 2026. The filing also lists Damas Jewellery LLC, Damas Jewellery DMCC, Damas Jewellery Kuwait Co. WLL, Damas Saudi Arabia Co. Ltd., Damas Doha Jewellery WLL, Damas Jewellery SPC and Damas Company WLL among the subsidiaries connected with the acquisition structure.

The final purchase-price allocation disclosed Rs 2,858 crore of total purchase consideration, including Rs 1,472 crore of net assets taken over, Rs 763 crore of identifiable brand-related intangible assets and Rs 623 crore of goodwill. It also includes a Rs 1,668 crore fair value of financial liability, which is deducted in arriving at the Rs 1,190 crore consideration paid.

What changed in Titan’s Damas purchase-price allocation?

Titan completed the Damas valuation exercise in the quarter ended 30 June 2026, within the measurement period under Indian Accounting Standard 103, or Ind AS 103. The acquisition amounts had initially been provisional because valuations of tangible assets and leases had not been finalised.

The final valuation reduced the fair value of tangible assets by Rs 24 crore and increased goodwill by Rs 24 crore in the June 2026 quarter. Titan said the Rs 623 crore goodwill primarily represents expected synergies and the value of the assembled workforce, and allocated it to the Damas cash-generating unit, or CGU.

Titan also said the Damas goodwill is not deductible for income-tax purposes. The Rs 24 crore adjustment was a purchase-accounting revision in the June quarter, whereas the Rs 671 crore gain was a September-quarter fair-value movement in the NCI put-option liability; the filing presents them as separate accounting events.

How does the gain compare with Titan’s other reported figures?

Titan’s Rs 671 crore put-option gain was Rs 48 crore higher than the Rs 623 crore goodwill in the final Damas allocation, but the figures have different functions. Goodwill is part of the purchase-price allocation for the 67% acquisition, while the September gain reflects a fall in the liability associated with the minority shareholders’ put option.

The filing reported geographic revenue including other income of Rs 21,430 crore for the quarter ended 30 September 2026, compared with Rs 18,837 crore a year earlier. India accounted for Rs 19,293 crore, compared with Rs 17,925 crore a year earlier, while rest-of-world revenue increased to Rs 2,137 crore from Rs 912 crore.

India revenue including other income was Rs 19,738 crore in the preceding quarter ended 30 June 2026, compared with Rs 19,293 crore in the September quarter. Rest-of-world revenue rose from Rs 1,764 crore in June 2026 to Rs 2,137 crore in September 2026, but the filing does not attribute either geographic movement specifically to Damas.

What do Titan’s reported margins show?

Titan reported an operating margin of 13.47% for the quarter ended 30 September 2026, compared with 12.76% in the preceding June quarter and 9.31% in the quarter ended 30 September 2025. Its net profit margin was 11.61%, compared with 8.32% and 5.98%, respectively.

Titan defines operating margin as profit before depreciation, interest on borrowings, exceptional items and tax, less other income, divided by revenue from operations. The filing does not provide a reconciliation that assigns the Rs 671 crore NCI put-option gain to either the 13.47% operating margin or the 11.61% net profit margin.

The Group identifies four operating verticals: Watches, Jewellery, Eyecare and Others. Others includes Aerospace and Defence, Automation Solutions, Accessories, Fragrances and Indian dress wear, while the September 2026 disclosure does not provide Damas-specific revenue, margin, store or product-volume data.

What should readers watch after Titan’s remeasurement?

Readers should watch future disclosures on the Damas NCI put-option liability because the minority shareholders’ option becomes exercisable on 31 December 2029. Titan has disclosed its call option and the matching minority put option over the remaining 33%, but has not disclosed the exercise price, later valuation inputs or expected funding requirement.

Titan’s additional disclosures showed a debt-equity ratio of 1.51 at 30 September 2026, compared with 1.01 at 30 June 2026 and 0.97 a year earlier. Total debt to total assets was 0.34 at 30 September 2026, against 0.22 in June 2026 and 0.19 in September 2025.

The consolidated unaudited results for the quarter and six months ended 30 September 2026 were approved by Titan’s board on 5 November 2026. The statutory auditors issued an unmodified limited-review report, so subsequent quarterly filings may provide further information on changes in the put-option liability before the 2029 exercise date.

Conclusion

Titan’s September 2026 consolidated reporting included a Rs 671 crore gain from remeasuring the Damas minority put-option liability. That gain is distinct from the Rs 1,190 crore paid for the 67% Damas interest, the Rs 623 crore goodwill recorded in the final allocation and the Rs 24 crore June 2026 valuation adjustment.

The next disclosed option milestone is 31 December 2029, when the Damas minority shareholders’ put option is exercisable. Until then, Titan’s quarterly filings can show whether the NCI put-option liability is remeasured again and whether the company adds detail on the liability’s valuation or funding implications.